EANO

🧠 Now published in Neuro-Oncology: “The prognostic impact of CDKN2A/B hemizygous deletions in #meningioma.” This new study, led by Franziska M. Ippen, builds on preliminary results previously presented at #EANO in Glasgow.
🔗 Learn more: doi.org/10.1093/neuo...

#EANOessentials #NeuroOncology

🧠 Just published in Nature Genetics: "A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning–based tumor classification."
🔗 www.nature.com/articles/s41...

#EANOessentials #NeuroOncology #Meningioma #MachineLearning #OpenAccess

🌟 Today is the International Day of Women and Girls in Science! At #EANO, we celebrate the vital contributions of women in #NeuroOncology and beyond.
Learn more about EANO's commitment to a diverse and equal community: www.eano.eu/about/about-...

🎗️ On World Cancer Day, we stand united. #EANO brings together experts across disciplines and borders to advance research, education, and care in neuro-oncology. Together, we continue to shape the future of cancer care. 💙

👉 Learn more: www.eano.eu

#WorldCancerDay #NeuroOncology #BrainTumors

Quote card showing a photo of neuro-oncologist Martin van den Bent, MD, PhD. "...for some of the questions that we are studying, you need to collaborate to make sure what you are finding is not just true at your institution about across institutions.

We’re pleased to welcome Martin van den Bent, MD, PhD, as an adjunct professor! In addition to mentoring faculty and residents, he is helping increase UCSF’s role in large international clinical trials: braintumorcenter.ucsf.edu/news/new-neu...
@eanoassociation.bsky.social @erasmusmc.bsky.social

Recently published in @cp-immunity.bsky.social: Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. 👉 Full article:
www.cell.com/immunity/ful...

#NeuroOncology #Glioma #OpenAccess #EANOessentials

🎉 We’re fully booked! Thank you for the overwhelming interest in the 4th SNO/EANO Highlights Webinar. We’re truly inspired by the strong engagement from the global #NeuroOncology community! @neuroonc.bsky.social

𝙍𝙚𝙢𝙞𝙣𝙙𝙚𝙧: 𝙍𝙚𝙜𝙞𝙨𝙩𝙚𝙧 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙀𝘼𝙉𝙊 𝙏𝙪𝙢𝙤𝙧 𝘽𝙤𝙖𝙧𝙙 𝟐𝟎𝟐𝟔
Following the successful first edition in Prague, the 2nd #EANOTumorBoard will take place on March 12, 2026, in Bucharest, RO, just before the #EANO Seminars.
🗓️ Registration deadline: February 23, 2026

www.eano.eu/eanomeetings...

Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group AbstractAbstract. BackgroundThe oncological role of resection in elderly patients with glioblastoma remains controversial. We evaluated the value of resect

Presented at #EANO2025 and published in Neuro Oncology: Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group by Philipp Karschnia et al
👉 Learn more: doi.org/10.1093/neuo...

#RANO #glioblastoma #surgery #EANOessentials

Multimodality mapping of immunotherapy distribution as a predictive marker in glioma AbstractBackground. Scarce T cell infiltration, immunosuppressive tumor-associated macrophages and ineffective drug delivery drive glioma progression and l

First presented at #EANO2024, this work has now been published in Neuro-Oncology.
👉 academic.oup.com/neuro-oncolo...

#NeuroOncology #EANO #Glioma #ResearchHighlights #EANOessentials

@lukasbunse.bsky.social @venkataramanilab.bsky.social
@wickwolfgang.bsky.social @michael-platten.bsky.social

📣 Join the 4th Annual EANO/SNO Highlights Webinar
Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology.
🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET
🎟 Free for #EANO & #SNO members
👉 Register now: bit.ly/EANO-SNO-2025
#NeuroOncology @neuroonc.bsky.social

Final results from the #CATNON trial by Martin van den Bent et al. have been published in @thelancetoncol.bsky.social, reporting on concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (EORTC 26053-22054).
👉 doi.org/10.1016/S147...
#NeuroOncology #Glioma @eortc.org

Join the #EANO Tumor Board 2026 on March 12 in Bucharest 🇷🇴 (prior to EANO Seminars 2026).
Five multidisciplinary, case-based discussions on glioma management, plus practical, evidence-based lectures.
Free for EANO members.
Register by Feb 23 👉 www.eano.eu/eanomeetings...
#NeuroOncology #TumorBoard

💫 Warm seasonal greetings to our #EANO community! 2025 highlighted the strength and collaboration of #NeuroOncology –made possible by your engagement and support. Wishing you joyful holidays and an inspiring New Year as we look ahead to EANO Seminars and Rome 2026.
Übersetzung anzeigen

YouTube video by EANO EANO Meeting 2025 in Prague

#EANO2025 in Prague 🇨🇿 – the highlights. One of our most successful meetings yet: record abstracts, outstanding multidisciplinary science, strong early-career engagement, and for the first time patient representatives. #NeuroOncology. 🎥 youtu.be/CWuMWef_mmI
See you in Rome for #EANO2026 🇮🇹

That was #EANO2025 – a congress full of inspiring progress in #NeuroOncology. Congrats to Thomas Millner from @qmul.bsky.social, winner of the Best Poster Award in Translational Research for his work on DNA methylation & neuroinflammation. 🎉
👉 academic.oup.com/neuro-oncolo... @qmul.bsky.social

#EANO2025 Recap: We are delighted to recognize Jan-Michael Werner for receiving the Best Poster Presentation in Clinical Research. Congratulations! 🎉
👉 Learn more about this abstract and all others on academic.oup.com/neuro-oncolo...

#NeuroOncology

@meduniwien.ac.at @uniklinikkoeln.bsky.social

#EANO2025 was full of inspiration and great science! 🎉
Congrats to Elisabetta Mori (Scuola Normale Superiore → @sns.it ), winner of the Best Poster Presentation Award in Basic Research for her work on CTX-CNF1 in glioblastoma (P18.12.A).
Learn more: academic.oup.com/neuro-oncolo...

Back to cold Vienna 🥶 after #SNO2025 #WFNOS2025 in Honolulu! 🌺🏝️
Great talks, inspiring discussions, presenting own data, catching up with friends & colleagues - all made even better by Hawaiian sunshine. 😎
Last conference of 2025 in the books. Looking forward to what’s next in 2026! 🚀 #btsm

🤩 💫 We are delighted to announce that the registration & abstract submission for the NMN Symposium 2026 to be held in Vienna from May 07-08th 2026 is open now!

Program: www.nmn-society.org/program/
Abstract submission: www.nmn-society.org/abstracts/
Registration: www.nmn-society.org/registration/

📣 EANO Seminars 2026 – one week left to apply! The next #EANO seminars will take place in Bucharest, Romania, on March 13–14, 2026.

🗓️ Application deadline: December 10, 2025
👉 Learn more and apply today: www.eano.eu/eanoseminars...

#EANO #EANO2026 #NeuroOncology #BrainTumour #CNS

@galldiks.bsky.social
@mj-mair.bsky.social
@jmwerner.bsky.social
@lena-rosenlund.bsky.social
@sjp58-cam.bsky.social

That’s a wrap on WFNOS/SNO 2025 in Honolulu, Hawaii!
The #EANO team truly enjoyed connecting with colleagues from around the world, exchanging insights, and celebrating SNO’s 30th anniversary. A big thank you to the @neuroonc.bsky.social for hosting this inspiring meeting! 🌺

#SNO2025 #WFNOS2025

🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Lighting up PET imaging in IDH mutant gliomas
👉 Missed the latest session? No worries – you can catch up by watching the recording on YouTube: youtu.be/0i9XVEjDs5c?...

We look forward to seeing you at our next session!

Start of the Educational Day of #SNO2025 and WFNOS2025. Welcoming by @mjlimfat.bsky.social. Looking forward to an inspiring conference in Honolulu. @neuroonc.bsky.social @eanoassociation.bsky.social

Are you a physician, nurse, researcher, technician, or allied health professional with an interest in #NeuroOncology?
Join the next #EANO Seminars, taking place in Bucharest, RO, on March 13–14, 2026!
- Application deadline: December 10, 2025
- Learn more & apply here:
👉 www.eano.eu/eanoseminars...

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma AbstractBackground. DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patien

Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! @neuroonc.bsky.social @eanoassociation.bsky.social @gelarehzadeh.bsky.social @icomeningioma.bsky.social

doi.org/10.1093/neuo...

@nmnsymposium.bsky.social @eanm.org

Awarded as best clinical science poster at #EANO2025 and now published online: "Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma" by @jmwerner.bsky.social and colleagues.
👉 link.springer.com/article/10.1...
#NuclearMedicine #Glioma #NeuroOncology #PETImaging

🧠 Thank you for joining us! The #EANOYoungsters #JournalClub on “Lighting up PET imaging in IDH mutant gliomas” brought together colleagues worldwide for a vibrant exchange on cutting-edge #NeuroOncology research.
▶️ Missed it? The recording will be available soon:
www.youtube.com/@eano_associ...